Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
8.36
+0.18 (2.20%)
At close: Dec 8, 2025, 4:00 PM EST
8.45
+0.09 (1.06%)
After-hours: Dec 8, 2025, 6:19 PM EST
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $170.63 million as of December 8, 2025. Its market cap has increased by 224.71% in one year.
Market Cap
170.63M
Enterprise Value
3.03M
1-Year Change
224.71%
Ranking
Category
Stock Price
$8.36
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $170.63M, a decrease of -86.86%. That is a compound annual growth rate of -34.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 166.96M | 20.77% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | 1.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |